This page does not seem to exist…
We apologize for the inconvenience, but the page you were trying to access is not at this address. You can use the links below to help you find what you are looking for.
If you are certain you have the correct web address but are encountering an error, please contact the Site Administration.
Thank you.
You might have been looking for…
- Our sector
- Positionspapier Braille on NTA 2013_final draft_ last update 2014 03 10
- Positionspapier Braille on NTA 2013_final draft_ last update 2014 03 10
- Timeline
- History of EU legal and regulatory environment for homeopathic and anthroposophic medicinal products; milestones 1965-2015
- 92/73/EEC
- 92/74/EEC
- A timeline: EU pharmaceutical regulation for homeopathic medicinal products 1992-2020
- ECHAMP’s new timeline provides an at-a-glance summary of the last thirty years of EU regulation for homeopathic medicinal products.
- HMPWG: Questions and answers document on regulatory and legal issues
- HMPWG’s new ‘Questions and answers document on regulatory and legal issues concerning homeopathic medicinal products’ confirms the high legal and regulatory ...
- ECHAMP responds to Study on the Availability of Medicinal Products for Human Use
- ECHAMP welcomes the specific attention this new study gives to the situation regarding the availability of homeopathic and anthroposophic medicinal products, ...
- Annex III.1: Survey on the Availability of Homeopathic and Anthroposophic Medicinal Products in five Member States of the EU - Background to the survey
- Annex III.1: Survey on the Availability of Homeopathic and Anthroposophic Medicinal Products in five Member States of the EU - Background to the survey
- Annex II.2: Regulatory Status of Homeopathic and Anthroposophic Medicinal Products - Survey report, PriceWaterhouseCoopers
- Annex II.2: Regulatory Status of Homeopathic and Anthroposophic Medicinal Products - Survey report, PriceWaterhouseCoopers
- 2011/62/EU